FDA Establishes Criteria for Bulk Drug Substances for Compounding Drug Products

Summary

The FDA is issuing a final rule to identify six bulk drug substances that can be used to compound drug products, excluding those subject to USP or NF monographs or FDA-approved drugs, and four substances that are not being included on the list, with additional nominations currently under consideration for future rulemaking.